Exact Mass: 281.072

Exact Mass Matches: 281.072

Found 89 metabolites which its exact mass value is equals to given mass value 281.072, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Nitrazepam

1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one

C15H11N3O3 (281.08)


Nitrazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative used as an anticonvulsant and hypnotic.Nitrazepam belongs to a group of medicines called benzodiazepines. It acts on benzodiazepine receptors in the brain which are associated with the GABA receptors causing an enhanced binding of GABA (gamma amino butyric acid) to GABAA receptors. GABA is a major inhibitory neurotransmitter in the brain, involved in inducing sleepiness, muscular relaxation and control of anxiety and fits, and slows down the central nervous system. The anticonvulsant properties of nitrazepam and other benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants CONFIDENCE standard compound; EAWAG_UCHEM_ID 3683

   

Flufenamic acid

N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid

C14H10F3NO2 (281.0664)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 3021 D000893 - Anti-Inflammatory Agents Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.

   

9-Riburonosyladenine

b-D-Ribofuranuronic acid,1-(6-amino-9H-purin-9-yl)-1-deoxy-

C10H11N5O5 (281.076)


   

MLS002694489

7-(Acetyloxy)-3-(3-pyridinyl)-2H-1-benzopyran-2-one

C16H11NO4 (281.0688)


   
   

7-Acetamido-9-oxofluorene-4-carboxylic acid

7-[(1-Hydroxyethylidene)amino]-9-oxo-9H-fluorene-4-carboxylate

C16H11NO4 (281.0688)


   

C1=CC=C2C3=C(O)C(OC)=CC(C(=O)N4O)=C3C4=CC2=C1

C1=CC=C2C3=C(O)C(OC)=CC(C(=O)N4O)=C3C4=CC2=C1

C16H11NO4 (281.0688)


   

Aristolactam AIIIa

Aristolactam AIIIa

C16H11NO4 (281.0688)


   

Buxifoliadine F

Buxifoliadine F

C16H11NO4 (281.0688)


   

Piperumbellactam C

Piperumbellactam C

C16H11NO4 (281.0688)


   
   
   
   

2-[4-(5-Methyl-3-phenylisoxazol-4-yl)-1,3-thiazol-2-yl]acetonitrile

2-[4-(5-Methyl-3-phenylisoxazol-4-yl)-1,3-thiazol-2-yl]acetonitrile

C15H11N3OS (281.0623)


   

Cheliensisam B

Cheliensisam B

C16H11NO4 (281.0688)


   

Aristolactam AIa

Aristolactam AIa

C16H11NO4 (281.0688)


   

Avenalumin 1|avenalumin I

Avenalumin 1|avenalumin I

C16H11NO4 (281.0688)


   

Aristololactam GII

Aristololactam GII

C16H11NO4 (281.0688)


   

CHEMBL2337113

CHEMBL2337113

C15H11N3O3 (281.08)


   

Aristolactam AIIIa

4,14-dihydroxy-15-methoxy-10-azatetracyclo[7.6.1.02,7.012,16]hexadeca-1,3,5,7,9(16),12,14-heptaen-11-one

C16H11NO4 (281.0688)


Aristolactam AIIIa is a natural product found in Aristolochia elegans, Aristolochia kaempferi, and other organisms with data available.

   

nitrazepam

nitrazepam

C15H11N3O3 (281.08)


A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (Wests syndrome). D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants CONFIDENCE standard compound; INTERNAL_ID 1535

   

flufenamic acid

flufenamic acid

C14H10F3NO2 (281.0664)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5428; ORIGINAL_PRECURSOR_SCAN_NO 5423 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5418; ORIGINAL_PRECURSOR_SCAN_NO 5416 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5457; ORIGINAL_PRECURSOR_SCAN_NO 5455 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5442; ORIGINAL_PRECURSOR_SCAN_NO 5441 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5524; ORIGINAL_PRECURSOR_SCAN_NO 5519 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5447; ORIGINAL_PRECURSOR_SCAN_NO 5445 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9133; ORIGINAL_PRECURSOR_SCAN_NO 9128 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9153; ORIGINAL_PRECURSOR_SCAN_NO 9148 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9175; ORIGINAL_PRECURSOR_SCAN_NO 9171 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9182; ORIGINAL_PRECURSOR_SCAN_NO 9178 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9162; ORIGINAL_PRECURSOR_SCAN_NO 9160 CONFIDENCE standard compound; INTERNAL_ID 367; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9196; ORIGINAL_PRECURSOR_SCAN_NO 9192 Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.

   

CAY10550

2,4-dihydro-5-(4-nitrophenyl)-2-phenyl-3H-pyrazol-3-one

C15H11N3O3 (281.08)


   

Benzyl 4-(chlorocarbonyl)-1-piperidinecarboxylate

Benzyl 4-(chlorocarbonyl)-1-piperidinecarboxylate

C14H16ClNO3 (281.0819)


   

(S)-4-((Benzyloxy)carbonyl)thiomorpholine-3-carboxylic acid

(S)-4-((Benzyloxy)carbonyl)thiomorpholine-3-carboxylic acid

C13H15NO4S (281.0722)


   

Benzenaminium, N,N,N-trimethyl-, hexafluorophosphate(1-)

Benzenaminium, N,N,N-trimethyl-, hexafluorophosphate(1-)

C9H14F6NP (281.0768)


   

2-Benzyl-1,3-dioxoisoindoline-5-carboxylic acid

2-Benzyl-1,3-dioxoisoindoline-5-carboxylic acid

C16H11NO4 (281.0688)


   
   

4-CBZ-THIOMORPHOLINE-3-CARBOXYLIC ACID

4-CBZ-THIOMORPHOLINE-3-CARBOXYLIC ACID

C13H15NO4S (281.0722)


   

4-(3-TRIFLUOROMETHYL-PHENOXY)-PIPERIDINE HYDROCHLORIDE

4-(3-TRIFLUOROMETHYL-PHENOXY)-PIPERIDINE HYDROCHLORIDE

C12H15ClF3NO (281.0794)


   

(3R)-4-phenylmethoxycarbonylthiomorpholine-3-carboxylic acid

(3R)-4-phenylmethoxycarbonylthiomorpholine-3-carboxylic acid

C13H15NO4S (281.0722)


   

1H-Indole,1-methyl-3-[5-(2-thienyl)-1,3,4-oxadiazol-2-yl]-(9CI)

1H-Indole,1-methyl-3-[5-(2-thienyl)-1,3,4-oxadiazol-2-yl]-(9CI)

C15H11N3OS (281.0623)


   

2-(3-Quinolinyl)aniline

2-(3-Quinolinyl)aniline

C12H15ClF3NO (281.0794)


   

5-Benzyl-3-(4-nitrophenyl)-1,2,4-oxadiazole

5-Benzyl-3-(4-nitrophenyl)-1,2,4-oxadiazole

C15H11N3O3 (281.08)


   

3-benzylhydroxy-2,6-dihydroxymethylpyridine hydrochloride

3-benzylhydroxy-2,6-dihydroxymethylpyridine hydrochloride

C14H16ClNO3 (281.0819)


   

1-(1,3-Benzodioxol-5-ylmethyl)-1H-indole-2,3-dione

1-(1,3-Benzodioxol-5-ylmethyl)-1H-indole-2,3-dione

C16H11NO4 (281.0688)


   

2-(N-(4-CHLOROPHENYL)CARBAMOYL)CYCLOHEXANECARBOXYLIC ACID

2-(N-(4-CHLOROPHENYL)CARBAMOYL)CYCLOHEXANECARBOXYLIC ACID

C14H16ClNO3 (281.0819)


   

N-Cyclopropyl-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine hydro bromide (1:1)

N-Cyclopropyl-N-methyl-1,2,3,4-tetrahydro-2-naphthalenamine hydro bromide (1:1)

C14H20BrN (281.0779)


   

N-(2,4-Dinitrophenyl)-D-proline

N-(2,4-Dinitrophenyl)-D-proline

C11H11N3O6 (281.0648)


   

3-Chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

3-Chloro-4-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile

C13H14BClFNO2 (281.079)


   

2-(4-Aminophenyl)imidazo[2,1-b][1,3]benzothiazol-7-ol

2-(4-Aminophenyl)imidazo[2,1-b][1,3]benzothiazol-7-ol

C15H11N3OS (281.0623)


   

3-AMINO-4-CHLOROBENZOICACID

3-AMINO-4-CHLOROBENZOICACID

C14H10F3NO2 (281.0664)


   

2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]benzoic acid

2-[(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]benzoic acid

C16H11NO4 (281.0688)


   
   

1-(4-trifluoromethyl)phenylbiguanide hydrochloride

1-(4-trifluoromethyl)phenylbiguanide hydrochloride

C9H11ClF3N5 (281.0655)


   

1-BENZYLOXYCARBONYLPIPERIDINE-3-CARBONYLCHLORIDE

1-BENZYLOXYCARBONYLPIPERIDINE-3-CARBONYLCHLORIDE

C14H16ClNO3 (281.0819)


   

1-Acetamido-4-hydroxyanthraquinone

1-Acetamido-4-hydroxyanthraquinone

C16H11NO4 (281.0688)


   

3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YLMETHYL)-BENZOIC ACID

3-(1,3-DIOXO-1,3-DIHYDRO-ISOINDOL-2-YLMETHYL)-BENZOIC ACID

C16H11NO4 (281.0688)


   

4-[3-(Trifluoromethyl)phenyl]-4-piperidinol hydrochloride

4-[3-(Trifluoromethyl)phenyl]-4-piperidinol hydrochloride

C12H15ClF3NO (281.0794)


   

2-(TRIFLUOROMETHYL)-6,11-DIHYDRO-5H-BENZO[B]PYRIDO[2,3-E][1,4]DIAZEPIN-7-OL

2-(TRIFLUOROMETHYL)-6,11-DIHYDRO-5H-BENZO[B]PYRIDO[2,3-E][1,4]DIAZEPIN-7-OL

C13H10F3N3O (281.0776)


   

3,5-BIS(ACETYLAMINO)-2-NITRO-BENZOIC ACID

3,5-BIS(ACETYLAMINO)-2-NITRO-BENZOIC ACID

C11H11N3O6 (281.0648)


   

1-ALLYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

1-ALLYL-7-PHENYL-1H-PYRIMIDO[4,5-D][1,3]OXAZINE-2,4-DIONE

C15H11N3O3 (281.08)


   

4-[2-(Trifluoromethyl)phenoxy]piperidine hydrochloride

4-[2-(Trifluoromethyl)phenoxy]piperidine hydrochloride

C12H15ClF3NO (281.0794)


   

4-Nitrobenzoylglycylglycine

4-Nitrobenzoylglycylglycine

C11H11N3O6 (281.0648)


   

N-(4-TRIFLUOROMETHYLPHENYL)ANTHRANILIC ACID

N-(4-TRIFLUOROMETHYLPHENYL)ANTHRANILIC ACID

C14H10F3NO2 (281.0664)


   

2-[2-(AMINOMETHYL)PHENYLTHIO]BENZYL ALCOHOL HYDROCHLORIDE

2-[2-(AMINOMETHYL)PHENYLTHIO]BENZYL ALCOHOL HYDROCHLORIDE

C14H16ClNOS (281.0641)


   

1-Butylpyridinium hexafluorophosphate

1-Butylpyridinium hexafluorophosphate

C9H14F6NP (281.0768)


   
   

N-(2,4-Dinitrophenyl)-L-proline

N-(2,4-Dinitrophenyl)-L-proline

C11H11N3O6 (281.0648)


The L-stereoisomer of N-(2,4-dinitrophenyl)proline, a proline derivative having a 2,4-dinitrophenyl substituent on nitrogen.

   

N-(2,4-Dinitrophenyl)proline

N-(2,4-Dinitrophenyl)proline

C11H11N3O6 (281.0648)


   

4-(4-(trifluoromethoxy)phenyl)piperidine hydrochloride

4-(4-(trifluoromethoxy)phenyl)piperidine hydrochloride

C12H15ClF3NO (281.0794)


   

(Z)-3-(hydroxy-phenyl-methylene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid

(Z)-3-(hydroxy-phenyl-methylene)-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid

C16H11NO4 (281.0688)


   
   

5-Acetyl-2-chloro-1-cyclopentyl-1,6-dihydro-4-methyl-6-oxo-3-pyridinecarboxaldehyde

5-Acetyl-2-chloro-1-cyclopentyl-1,6-dihydro-4-methyl-6-oxo-3-pyridinecarboxaldehyde

C14H16ClNO3 (281.0819)


   

1-BOC-4-CHLORO-3-HYDROXYMETHYLINDOLE

1-BOC-4-CHLORO-3-HYDROXYMETHYLINDOLE

C14H16ClNO3 (281.0819)


   

O-Trifluoromethylphenyl anthranilic acid

O-Trifluoromethylphenyl anthranilic acid

C14H10F3NO2 (281.0664)


   

7-Acetamido-9-oxofluorene-4-carboxylic acid

7-Acetamido-9-oxofluorene-4-carboxylic acid

C16H11NO4 (281.0688)


   

VEGF Inducer, GS4012

VEGF Inducer, GS4012

C14H16ClNOS (281.0641)


   

2-(1H-benzimidazol-2-yl)-1-(3-nitrophenyl)ethanone

2-(1H-benzimidazol-2-yl)-1-(3-nitrophenyl)ethanone

C15H11N3O3 (281.08)


   

(2R)-2-acetamido-3-phenacylsulfanylpropanoic acid

(2R)-2-acetamido-3-phenacylsulfanylpropanoic acid

C13H15NO4S (281.0722)


   

2-(1,3-Benzodioxol-5-ylmethyl)isoindole-1,3-dione

2-(1,3-Benzodioxol-5-ylmethyl)isoindole-1,3-dione

C16H11NO4 (281.0688)


   

N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide

N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide

C12H15N3OS2 (281.0656)


   

1-(3,5-Dimethyl-isoxazol-4-ylmethyl)-2,3-dioxo-2,3-dihydro-1H-indole-5-carbonitrile

1-(3,5-Dimethyl-isoxazol-4-ylmethyl)-2,3-dioxo-2,3-dihydro-1H-indole-5-carbonitrile

C15H11N3O3 (281.08)


   

3-methoxy-N-(2,3,4-trifluorophenyl)benzamide

3-methoxy-N-(2,3,4-trifluorophenyl)benzamide

C14H10F3NO2 (281.0664)


   

2-Chloro-4,6-diphenyl-5-pyrimidinamine

2-Chloro-4,6-diphenyl-5-pyrimidinamine

C16H12ClN3 (281.072)


   
   
   

1-Hydroxy-6-nitro-2-phenyl-3-indazol-2-iumcarbonitrile

1-Hydroxy-6-nitro-2-phenyl-3-indazol-2-iumcarbonitrile

C14H9N4O3+ (281.0675)


   

7-(Acetyloxy)-3-(3-pyridinyl)-2H-1-benzopyran-2-one

7-(Acetyloxy)-3-(3-pyridinyl)-2H-1-benzopyran-2-one

C16H11NO4 (281.0688)


   

TFAP

TFAP

C13H10F3N3O (281.0776)


TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor, with an IC50 of 0.8 μM.

   

(2z)-6-hydroxy-2-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)ethylidene]-1h-3,1-benzoxazin-4-one

(2z)-6-hydroxy-2-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)ethylidene]-1h-3,1-benzoxazin-4-one

C16H11NO4 (281.0688)


   

15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaene-6,11,14-triol

15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaene-6,11,14-triol

C16H11NO4 (281.0688)


   

10-hydroxy-5-methoxy-11h-furo[2,3-c]acridin-6-one

10-hydroxy-5-methoxy-11h-furo[2,3-c]acridin-6-one

C16H11NO4 (281.0688)


   

avenalumin i

NA

C16H11NO4 (281.0688)


{"Ingredient_id": "HBIN017401","Ingredient_name": "avenalumin i","Alias": "NA","Ingredient_formula": "C16H11NO4","Ingredient_Smile": "C1=CC(=O)C=CC1=CC=C2NC3=C(C=C(C=C3)O)C(=O)O2","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

6-hydroxy-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-iminopurin-8-one

6-hydroxy-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-iminopurin-8-one

C10H11N5O5 (281.076)


   

15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaene-4,11,14-triol

15-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,10,12,14-octaene-4,11,14-triol

C16H11NO4 (281.0688)


   

14,15-dihydroxy-10-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-11-one

14,15-dihydroxy-10-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-11-one

C16H11NO4 (281.0688)


   

10,15-dihydroxy-14-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-11-one

10,15-dihydroxy-14-methoxy-10-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2(7),3,5,8,12,14-heptaen-11-one

C16H11NO4 (281.0688)


   

6-(methoxycarbonyl)phenazine-1-carboximidic acid

6-(methoxycarbonyl)phenazine-1-carboximidic acid

C15H11N3O3 (281.08)